Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs. The research and development department in Celon Pharma S.A.employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy or chemistry.
We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. We have obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative
Management Celon Pharma S.A.
Maciej Wieczorek, PhD, CEO
President of the Management Board
Dorota Zwolińska, CFO,
Member of The Management Board
Robert Rzemiński – Chairman of the Supervisory Board
Bogusław Galewski – Member of the Supervisory Board
Urszula Wieczorek – Member of the Supervisory Board
Artur Wieczorek – Member of the Supervisory Board
Krzysztof Kaczmarczyk – Member of the Supervisory Board